Home/ Supplements/ Electrolytes/ SBF Formula

SBF Formula

product on market Tablet or Pill Endo-met Laboratories Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 55% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

This formula contains essential minerals and vitamins, including magnesium and potassium, which support nerve function and electrolyte balance. Choline and B-vitamins are linked to cognitive health and metabolic processes. There is strong evidence for the general roles of these nutrients, though overall evidence coverage for this specific combination is limited.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for SBF Formula
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Tablet(s)
Serving Size
180
Servings
Other Combinations
Product Type
55%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

120 mg (29% DV)
Within RDA (0.3× RDA) 316 studies (A:8, B:159)
40 mg (7% DV)
Within RDA (0.1× RDA) 38 studies (A:1, B:7)
Potassium
20 mg (1% DV)
10 mg (833% DV)
8.3× RDA — above typical dose 76 studies (A:0, B:33)
1 mg (111% DV)
1.1× RDA — within safe limits 37 studies (A:0, B:11)
50 mcg (91% DV)
Within RDA (0.9× RDA) 173 studies (A:0, B:67)
2.5 mcg (13% DV)
Within RDA (0.2× RDA) 608 studies (A:16, B:251)
100 mg
Market median: 500.0mg (193 products) 7 studies — no high-quality reviews
Thymus Substance
50 mg
L-Glutathione
500 mcg
Parathyroid Substance
140 mcg

Other Ingredients

Microcrystalline Cellulose Croscarmellose Sodium Magnesium Vegetable Stearate Stearic Acid Silica Film Coating
Claims

Label Claims — Verification

Unverified All Other
Info

Product Information

Directions for Use

Suggested use: One tablet daily, or as directed by a physician.

Warnings & Precautions

Notice: It is advisable to keep this and all supplements out of the reach of children.

Additional Information

Am noon pm

Metadata

Product Details

DSLD Entry Date2020-07-23
Product TypeOther Combinations
FormTablet or Pill
DSLD ID229042
Data Updated2026-04-11
Research

Research Evidence

849
Research Sources
56
Avg Quality
450
Meta Analysis
152
Rct
137
Systematic Review
73
Clinical Trial
11
Regulatory Source
7
Other
7
Guideline
3
Openfda Safety
2
Cochrane Review
2
Observational
A Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2015 PubMed DOI
A Vitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people in mid and late life
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems
Meta Analysis The Cochrane database of systematic reviews 2025 PubMed DOI
A Dietary calcium supplementation for preventing colorectal cancer and adenomatous polyps
Systematic Review The Cochrane database of systematic reviews 2008 PubMed DOI
A Calcium and vitamin D for increasing bone mineral density in premenopausal women
Systematic Review The Cochrane database of systematic reviews 2023 PubMed DOI
A Dietary sodium, sodium-to-potassium ratio, and risk of stroke: A systematic review and nonlinear dose-response meta-analysis
Meta Analysis Clinical nutrition (Edinburgh, Scotland) 2019 PubMed DOI
A The association between circulating magnesium and clinically relevant outcomes in patients with chronic kidney disease: A systematic review and meta-analysis
Meta Analysis Clinical nutrition (Edinburgh, Scotland) 2021 PubMed DOI
A Calcium channel blockers versus other classes of drugs for hypertension
Systematic Review The Cochrane database of systematic reviews 2021 PubMed DOI
View all evidence for Electrolytes →
Compare

Similar Products

View all Electrolytes products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.